Detalles de la búsqueda
1.
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.
Blood
; 114(6): 1166-73, 2009 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-19470696
2.
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy.
Breast Cancer Res Treat
; 110(2): 327-35, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17851757
Resultados
1 -
2
de 2
1
Próxima >
>>